Federal Register / Vol. 82, No. 204 / Tuesday, October 24, 2017 / Notices 49209 

The applications listed below, as well 

as other related filings required by the 

Board, are available for immediate 

inspection at the Federal Reserve Bank 

indicated. The applications will also be 

available for inspection at the offices of 

the Board of Governors. Interested 

persons may express their views in 

writing on the standards enumerated in 

the BHC Act (12 U.S.C. 1842(c)). If the 

proposal also involves the acquisition of 

a nonbanking company, the review also 

includes whether the acquisition of the 

nonbanking company complies with the 

standards in section 4 of the BHC Act 

(12 U.S.C. 1843). Unless otherwise 

noted, nonbanking activities will be 

conducted throughout the United States. 

Unless otherwise noted, comments 

regarding each of these applications 

must be received at the Reserve Bank 

indicated or the offices of the Board of 

Governors not later than November 16, 

2017. 

A. Federal Reserve Bank of Richmond 

(Adam M. Drimer, Assistant Vice 

President) 701 East Byrd Street, 

Richmond, Virginia 23261–4528. 

Comments can also be sent 

electronically to 

Comments.applications@rich.frb.org: 

1. Hamilton Bancorp, Inc.; to become 

a bank holding company by acquiring 

100 percent of the voting shares of 

Hamilton Bank, both of Towson, 

Maryland. 

B. Federal Reserve Bank of Atlanta 

(Kathryn Haney, Director of 

Applications) 1000 Peachtree Street, 

NE., Atlanta, Georgia 30309. Comments 

can also be sent electronically to 

Applications.Comments@atl.frb.org: 

1. Lakeside Bancshares, Inc.; to 

become a bank holding company by 

acquiring 100 percent of the outstanding 

shares of Lakeside Bank, both of Lake 

Charles, Louisiana. 

C. Federal Reserve Bank of Dallas 

(Robert L. Triplett III, Senior Vice 

President) 2200 North Pearl Street, 

Dallas, Texas 75201–2272: 

1. Henderson Citizens Bancshares, 

Inc., Henderson, Texas; to acquire 

voting shares of Union State Bancshares, 

Inc., Florence, Texas, and therefore 

indirectly acquire shares of Union State 

Bank, Florence, Texas. 

Board of Governors of the Federal Reserve 

System, October 18, 2017. 

Ann Misback, 

Secretary of the Board. 

[FR Doc. 2017–22963 Filed 10–23–17; 8:45 am] 

BILLING CODE P 

GENERAL SERVICES 

ADMINISTRATION 

[OMB Control No. 3090–0163; Docket 2017– 

0001; Sequence 5] 

Submission for OMB Review; General 

Services Acquisition Regulation; 

Information Specific to a Contract or 

Contracting Action (Not Required by 

Regulation) 

AGENCY: Office of Acquisition Policy, 

General Services Administration (GSA). 

ACTION: Notice of request for public 

comments regarding an extension to an 

existing OMB information collection. 

SUMMARY: Under the provisions of the 

Paperwork Reduction Act, the 

Regulatory Secretariat Division will be 

submitting to the Office of Management 

and Budget (OMB) a request to review 

and approve an extension of a 

previously approved information 

collection requirement regarding 

Information Specific to a Contract or 

Contracting Action (not required by 

regulation). A notice was published in 

the Federal Register at 82 FR 33911 on 

July 21, 2017. No comments were 

received. 

DATES: Submit comments on or before: 

November 24, 2017. 

ADDRESSES: Submit comments 

identified by Information Collection 

3090–0163, Information Specific to a 

Contract or Contracting Action (Not 

Required by Regulation), by any of the 

following methods: 

• Regulations.gov: http://

www.regulations.gov. Submit comments 

via the Federal eRulemaking portal by 

searching the OMB control number 

3090–0163. Select the link ‘‘Comment 

Now’’ that corresponds with 

‘‘Information Collection 3090–0163, 

Information Specific to a Contract or 

Contracting Action (Not Required by 

Regulation)’’. Follow the instructions 

provided on the screen. Please include 

your name, company name (if any), and 

‘‘Information Collection 3090–0163, 

Information Specific to a Contract or 

Contracting Action (Not Required by 

Regulation),’’ on your attached 

document. 

• Mail: General Services 

Administration, Regulatory Secretariat 

Division (MVCB), 1800 F Street NW., 

Washington, DC 20405. ATTN: Mr. Poe/ 

IC 3090–0163, Information Specific to a 

Contract or Contracting Action (Not 

Required by Regulation). 

Instructions: Please submit comments 

only and cite Information Collection 

3090–0163, Information Specific to a 

Contract or Contracting Action (Not 

Required by Regulation), in all 

correspondence related to this 

collection. Comments received generally 

will be posted without change to http:// 

www.regulations.gov, including any 

personal and/or business confidential 

information provided. To confirm 

receipt of your comment(s), please 

check www.regulations.gov, 

approximately two to three days after 

submission to verify posting (except 

allow 30 days for posting of comments 

submitted by mail). 

FOR FURTHER INFORMATION CONTACT: Ms. 

Jennifer Calik, Procurement Analyst, 

GSA Acquisition Policy Division, at 

telephone 312–353–6090 or email 

jennifer.calik@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

GSA has various mission 

responsibilities related to the 

acquisition and provision of supplies, 

transportation, information technology, 

telecommunications, real property 

management, and disposal of real and 

personal property. These mission 

responsibilities generate requirements 

that are realized through the solicitation 

and award of public contracts. In Fiscal 

Year 2016, these contracts had values 

ranging from under $100 to over 

$777,000,000, including the base and all 

options. 

Most GSA procurement-related 

information collections are required by 

the Federal Acquisition Regulation 

(FAR) or General Services 

Administration Acquisition Regulation 

(GSAR); each clause requiring such a 

collection must be individually 

approved by OMB. However, some 

solicitations require contractors to 

submit information specific to that 

contracting action, such as information 

needed to evaluate offers (e.g. specific 

instructions for technical and price 

proposals, references for past 

performance) or data used to administer 

resulting contracts (e.g. project 

management plans). 

This information collection is 

currently associated with GSA’s 

information collection requirements 

contained in solicitations issued in 

accordance with the Uniform Contract 

Format under FAR Part 14, Sealed 

Bidding (see GSAR 514.201–1); FAR 

Part 15, Contracting by Negotiation (see 

GSAR 515.204–1); and solicitations 

under FAR Part 12, Acquisition of 

Commercial Items, when issued in 

accordance with the policy and 

procedures of FAR Part 14 and FAR Part 

15 (see GSAR 512.301). This includes 

information collection requirements 

found in GSA Federal Supply Schedule 

(FSS) solicitations. 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
49210 Federal Register / Vol. 82, No. 204 / Tuesday, October 24, 2017 / Notices 

B. Annual Reporting Burden 

Respondents: 347,239. 

Responses per Respondent: 1. 

Total Responses: 347,239. 

Hours per Response: 40. 

Total Burden Hours: 138,896. 

C. Public Comments 

Public comments are particularly 

invited on: Whether this collection of 

information is necessary, whether it will 

have practical utility; whether our 

estimate of the public burden of this 

collection of information is accurate, 

and based on valid assumptions and 

methodology; ways to enhance the 

quality, utility, and clarity of the 

information to be collected; and ways in 

which we can minimize the burden of 

the collection of information on those 

who are to respond, through the use of 

appropriate technological collection 

techniques or other forms of information 

technology. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat Division (MVCB), 

1800 F Street, Washington, DC 20405, 

telephone 202–501–4755. 

Please cite OMB Control No. 3090– 

0163, Information Specific to a Contract 

or Contracting Action (Not Required by 

Regulation), in all correspondence. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2017–23027 Filed 10–23–17; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2017–N–5436] 

Electronic Study Data Submission; 

Data Standards; Support for Version 

Update of World Health Organization 

Drug Global 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or Agency) is 

announcing support for the most current 

B3-format annual version of the World 

Health Organization (WHO) Drug Global 

(WHODG) (formerly named WHO Drug 

Dictionary) (available at https://

www.who-umc.org), end of support for 

earlier versions of WHODG, and an 

update to the FDA Data Standards 

Catalog (Catalog) for study data 

provided in new drug applications 

(NDAs), abbreviated new drug 

applications (ANDAs), biologics license 

applications (BLAs), and certain 

investigational new drug applications 

(INDs) to the Center for Biologics 

Evaluation and Research (CBER) and the 

Center for Drug Evaluation and Research 

(CDER). 

ADDRESSES: You may submit either 

electronic or written comments at any 

time as follows: 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2017–N–5436 for ‘‘Electronic Study 

Data Submission; Data Standards; 

Support for Version Update of World 

Health Organization Drug Global.’’ 

Received comments will be placed in 

the docket and, except for those 

submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://www.gpo.gov/ 

fdsys/pkg/FR-2015-09-18/pdf/2015- 

23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 

heading of this document, into the 

‘‘Search’’ box and follow the prompts 

and/or go to the Dockets Management 

Staff, 5630 Fishers Lane, Rm. 1061, 

Rockville, MD 20852. 

FOR FURTHER INFORMATION CONTACT: Ron 

Fitzmartin, Center for Drug Evaluation 

and Research, Food and Drug 

Administration, 10903 New Hampshire 

Ave., Bldg. 51, Rm. 1115, Silver Spring, 

MD 20993–0002, 301–796–5333, email: 

cderdatastandards@fda.hhs.gov; or 

Stephen Ripley, Center for Biologics 

Evaluation and Research, Food and 

Drug Administration, 10903 New 

Hampshire Ave., Bldg. 71, Rm. 7301, 

Silver Spring, MD 20993–0002, 240– 

402–7911. 

SUPPLEMENTARY INFORMATION: 


asabaliauskas on DSKBBXCHB2PROD with NOTICES